Abstract
Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is implicated in liver cell proliferation. However, its role in hepatic steatosis and insulin resistance remain poorly understood. The aim of this study was to investigate the effects of MALAT1 on hepatic lipid accumulation and its potential targets. As expected, MALAT1 expression is increased in hepatocytes exposed to palmitate and livers of ob/ob mice. Knockdown of MALAT1 expression dramatically suppressed palmitate-induced lipid accumulation and the increase of nuclear SREBP-1c protein in HepG2 cells. In addition, RNA immunoprecipitation and RNA pull-down assay confirmed that MALAT1 interacted with SREBP-1c to stabilize nuclear SREBP-1c protein. Finally, injection of si-MALAT1 prevented hepatic lipid accumulation and insulin resistance in ob/ob mice. In conclusion, our observations suggest that MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability.
Highlights
ObjectivesThe aim of this study was to investigate the effects of MALAT1 on hepatic lipid accumulation and its potential targets
The present study firstly demonstrated that excess palmitate increased LncRNA MALAT1 expression, activated Sterol regulatory element-binding protein (SREBP)-1c, and induced intracellular lipid accumulation in hepatocytes
We found that MALAT1 expression is increased in hepatocytes exposed to palmitate and livers of ob/ob mice
Summary
The aim of this study was to investigate the effects of MALAT1 on hepatic lipid accumulation and its potential targets
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
